Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fine USA Trading is an active consumer health and nutraceutical company that markets Japanese-made beauty and wellness supplements in the United States. The business appears to operate as the U.S. arm of Fine Japan, a long-running Osaka-based manufacturer that says it has conducted in-house research and manufacturing since 1974 and maintains GMP, ISO9001, and Organic JAS certifications. Its commercial portfolio includes supplements such as nattokinase tablets, collagen and hyaluron formulations, probiotics, kelp root extract, vitamin products, hydrogen capsules, and functional beverages. The company is not a drug-development biotech and does not appear to run a clinical-stage pharmaceutical pipeline; instead, it focuses on branded and private-label nutraceutical, food, and cosmetic products for wellness and beauty markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fine USA Trading.